Spectral domain OCT can differentiate the retinal morphological changes of patients with Parkinson's disease in clinical middle stages.
Jiang HuangQingping WangKai LiQin ZhangGuoxu XuJing LiuJi ZhangTongtong NiuQilin ZhangWeifeng LuoPublished in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2020)
SD-OCT examination can detect the changes in retinal morphology in PD patients, and it may not be found the difference until the patients are in the H-Y III stage (the middle stage of PD).